Companies / C4 Therapeutics, Inc. / Activity
Activity — C4 Therapeutics, Inc.
10 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Platinum Investment Management Ltd 13F manager | New | Common Stock | $1.01M | +385K | 384,766 0.31% of shares | low |
| Q2 2026 as of | Deutsche Bank AG 13F manager | New | Common Stock | $461.7K | +99K | 98,873 0.08% of shares | low |
| Q1 2026 as of | Prelude Capital Management, LLC 13F manager | New | Common Stock | $81.4K | +31K | 30,957 0.03% of shares | low |
| Q3 2025 as of | Farallon Capital Management LLC 13F manager | New | Common Stock | $62.2K | +28K | 28,000 0.02% of shares | low |
| Q2 2026 as of | Victory Capital Management, Inc. 13F manager | New | Common Stock | $54.1K | +12K | 11,582 <0.01% of shares | low |
| Q2 2026 as of | WINTON GROUP Ltd 13F manager | New | Common Stock | $51.8K | +11K | 11,100 <0.01% of shares | low |
| Q4 2025 as of | Blackston Financial Advisory Group, LLC 13F manager | New | Common Stock | $19.1K | +10K | 10,000 <0.01% of shares | low |
| Q4 2021 as of | Leonteq Securities AG 13F manager | New | Common Stock | $15.5K | +480 | 480 <0.01% of shares | low |
| Q1 2026 as of | Federated Hermes Inc 13F manager | New | Common Stock | $4.9K | +2K | 1,878 <0.01% of shares | low |
| Q1 2026 as of | Hantz Financial Services, Inc. 13F manager | New | Common Stock | $0 | +3 | 3 <0.01% of shares | low |